Related Experiment Video
Updated: Jun 24, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Unusual metastases from extremity soft tissue sarcomas
Mark Ryzewicz1, Heather A McLoughlin, Curt Freudenberger
1Department of Orthopedics, University of Colorado Health Sciences Center, 4200 E 9th Ave, Mail Stop B202, Denver, CO 80262, USA.
Orthopedics
|March 19, 2009
Summary
Unusual recurrence of high-grade extremity soft-tissue sarcomas can occur outside the lungs. A review suggests a revised follow-up strategy for these rare but treatable distant metastases.
Area of Science:
- Oncology
- Surgical Pathology
- Medical Research
Background:
- Extremity soft-tissue sarcomas commonly metastasize to the lungs via the venous system.
- Metastases to distant sites like the brain or liver are considered rare.
- Current follow-up strategies primarily focus on pulmonary surveillance.
Purpose of the Study:
- To investigate the incidence and characteristics of unusual metastatic spread in high-grade extremity soft-tissue sarcomas.
- To evaluate the outcomes of patients experiencing extrapulmonary, distant recurrence.
- To propose an adjusted follow-up protocol based on observed metastatic patterns.
Main Methods:
- Review of a prospectively maintained tumor registry since 1986.
- Evaluation of 346 high-grade extremity soft-tissue sarcomas from a total of 3671 tumors.
- Analysis of patient data focusing on initial recurrence patterns and treatment outcomes.
Main Results:
- 15 patients (4.3%) presented with initial recurrence distant from the primary tumor and outside the lungs.
- Four of these 15 patients (27%) achieved successful treatment for their recurrence.
- Extrapulmonary metastases, though rare, represent a treatable subset of disease recurrence.
Conclusions:
- The incidence of extrapulmonary, distant recurrence in high-grade extremity soft-tissue sarcomas warrants consideration.
- Successful treatment outcomes in this subgroup suggest the need for broader surveillance.
- A revised follow-up strategy may improve detection and management of rare metastatic patterns.
